OBIO Announces Pre-Capital Access Advisory Program For 2016

Boosting Investability of Ontario Bioscience Companies

TORONTO--(BUSINESS WIRE)--Ontario Bioscience Innovation Organization (OBIO®) today announced the 2016 Pre-Capital Access Advisory Program (Pre-CAAP), a program in support of Ontario’s early stage bioscience companies. With access to capital as the number one challenge for bioscience start-ups in Ontario, Pre-CAAP combined with OBIO’s distinctive Capital Access Advisory Program (CAAP®) provides companies with key knowledge and insights to position them for financing and commercial success.

“Building on the momentum generated by last year’s successful program, Pre-CAAP 2016 will continue to benefit a broad spectrum of participants through a unique suite of tailored workshops, one-on-one advice and opportunities to meet with peers and thought leaders as they scale their companies”

“Building on the momentum generated by last year’s successful program, Pre-CAAP 2016 will continue to benefit a broad spectrum of participants through a unique suite of tailored workshops, one-on-one advice and opportunities to meet with peers and thought leaders as they scale their companies,” said Gail Garland, President and CEO of OBIO. “We recognize the need to help equip all companies interested in applying to our exclusive CAAP program, and thank the Federal Government, the Government of Ontario and our corporate sponsor Norton Rose Fulbright for their support of these important initiatives.”

Developed by OBIO and led by industry experts, Pre-CAAP is of particular relevance to companies that are in the process of raising or will have raised “seed” or later rounds of financing by the end of 2016 and plan to apply for the next cycle of OBIO CAAP. Pre-CAAP provides a full year of workshops, coaching and networking starting in mid-February. A full suite of topics are addressed at a ‘pitch perfect’ level including branding, health economics, valuation and others identified as priority by the health science industry.

Pre-CAAP is offered to all private Ontario companies focused on developing life science products or services including therapeutics, medical devices, diagnostics or healthcare information technologies. All companies that meet certain simple eligibility criteria are invited to register and participate in Pre-CAAP. Additional information about Pre-CAAP can be found on the OBIO website here.

To ensure maximum benefit from the program, companies are encouraged to register by February 15^th, 2016 although registrations are welcomed throughout the year. The registration form including eligibility criteria can be found here.

OBIO will hold an information session on Pre-CAAP by webinar February 1st, 2016 at 12 noon. To register for this session, click here.

Pre-CAAP is free for OBIO members. OBIO has a special discounted membership fee of $200 plus HST for companies that have raised less than C$500,000 which will allow companies to join Pre-CAAP and access all OBIO member benefits.

For additional information on Pre-CAAP please contact Klaus Fiebig, CAAP Senior Director, Strategic Programs at KlausFiebig@obio.ca.

About OBIO CAAP
CAAP is a unique, industry-led program, designed to enhance the investment-readiness profiles of Ontario health science companies. CAAP operates downstream from existing entrepreneurship programs and targets the critical issues of access to capital at the “Series A” and later stages of private financing. Led by OBIO and a North American Steering Committee of life science venture capitalists and serial entrepreneurs, OBIO CAAP companies work closely with a team of CAAP Advisors to position them for successful fundraising. OBIO CAAP is supported in part by the Federal Economic Development Agency for Southern Ontario and the Province of Ontario.

For more information on OBIO CAAP, visit the OBIO website here.

About OBIO
The Ontario Bioscience Innovation Organization (OBIO®) is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy for Ontario and one that will become a global leader in providing health technology products and services to the international marketplace. OBIO advances this goal through advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government.

For more information, visit the OBIO website www.obio.ca and follow OBIO on Twitter @OntBioscience.